Who makes Photocil for Psoriasis?

Photocil for Psoriasis is developed by Applied Biology, Inc..

What development phase is Photocil for Psoriasis in?

Photocil for Psoriasis is in Phase 1.

Last reviewed 2026-04-20 · How we verify

Photocil for Psoriasis

Applied Biology, Inc. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	Photocil for Psoriasis
Also known as	Photocil for Psoriasis (U.S. FDA NDC: 54841-001-01)
Sponsor	Applied Biology, Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Photocil (Topical) for the Treatment of Psoriasis Vulgaris (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Photocil for Psoriasis CI brief — competitive landscape report
Photocil for Psoriasis updates RSS · CI watch RSS
Applied Biology, Inc. portfolio CI